DEBORAH TRIGLIA: Open Payments
NPI 1316337769 · NEW PORT RICHEY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,900 in 66 payments from 10 companies in 2025. Trend: 2023 $657 · 2024 $1,160 · 2025 $1,900
Food & beverage: $1,900
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $408 |
| Novo Nordisk Inc | 13 | $362 |
| Amgen Inc. | 10 | $343 |
| PFIZER INC. | 13 | $282 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $167 |
| GlaxoSmithKline, LLC. | 5 | $106 |
| Exact Sciences Corporation | 5 | $78 |
| Lilly USA, LLC | 4 | $75 |
| ABBVIE INC. | 3 | $54 |
| SI-BONE, INC. | 1 | $24 |
Products named: NURTEC ODT, BREZTRI, OTEZLA, Wegovy, XIFAXAN, REPATHA, FARXIGA, Ozempic.
Industry payments across FL — which companies pay providers there.
